Country: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
lincomycin hydrochloride neomycin sulfate
Zoetis Ireland Limited
QJ51RF03
330/100 mg/syringe
intramammary Solution
Bovine
Antibacterial
Authorised
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Intramammary Solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Lactating cow. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mastitis in lactating cattle. The product is effective against Staphylococcus species (both penicillinase and non-penicillinase producers) including _Staphylococcus aureus, _Streptococcus species including _Streptococcus_ _agalactiae, Streptococcus dysgalactiae _and _Streptococcus uberis, _and coliform bacteria including _Escherichia coli_. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each 10 ml syringe contains: Active substances Lincomycin (as Lincomycin Hydrochloride) 330 mg Neomycin (as Neomycin Sulphate) 100 mg HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 18/07/2014_ _CRN 7018025_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid contact with the solution. Wash hands and any exposed skin immediately. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known. 4.7 USE DURING PREGNANCY, LACTATION OR LAY No restrictions. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERA Aqra d-dokument sħiħ